(Figure 1B). After stirring for 24 h, dithiothreitol was added
to the reaction mixture, and the product, Lys-Asp-Ala-Gln-
Ala-Gly-Lys-Glu-Pro-Gly-(Dmmb)Gly-Ser-Arg-Ala-His-Ser-
Ser-His-Leu-Lys-NH2 (12),20 was purified by RP-HPLC. The
Dmmb group was removed by treatment with trifluo-
romethanesufonic acid (TFMSA) in TFA to give Lys-Asp-
Ala-Gln-Ala-Gly-Lys-Glu-Pro-Gly-Gly-Ser-Arg-Ala-His-
Ser-Ser-His-Leu-Lys-NH2 (13).21
The condensation of NR-2-mercaptobenzyl peptides with
peptide thioesters has been examined by Offer and Dawson.8
The N-2-mercaptobenzyl group on the backbone of peptide
is too stable at acidic conditions even under conditions of
hydrogen fluoride treatment.8 The introduction of two
methoxy groups on the benzene ring permitted the Dmmb
group to be removed by treatment with 1 M TFMSA in TFA.
In conclusion, we reported the successful preparation of
a thiol linker-attached peptide, for condensation with the
peptide thioesters, from a nonprotected peptide via periodate
oxidation of the N-terminal serine residue, and reductive
amination with the Dmmb amine derivative. Transamination
reaction of N-terminal amino groups would also be used
instead of the periodate oxidation of serine and threonine
residues, in principle, though the stereochemistry, formed
in the reductive amination, should be controlled. After the
condensation with a peptide thioester, the thiol linker can
be removed by treatment with an acid, such as TFMSA.
Figure 1. RP-HPLC elution profiles of the reaction mixtures. (A)
Reductive amination product 9. (B) Condensation product 12. An
arrow, 14, indicates thiophenyl ester derived from peptide 11.
Column: Cosmosil 5C18AR-II (4.6 × 150 mm), eluent 0.1% TFA
in aqueous acetonitrile, 1.0 mL/min.
Acknowledgment. This research was supported, in part,
by a Grant-in-Aid for Scientific Research (10179103 and
12780440) from the Ministry of Education, Science, Sports
and Culture, Japan.
OL0157813
followed by trifluoroacetic acid (TFA) containing triisopro-
pylsilane to give the NR-Dmmb peptide 10.17
(18) Starting from Boc-Gly-SCH2CH2CO-Leu-OCH2-Pam resin,2 the
peptide chain was elongated by means of a peptide synthesizer 430A
(Applied Biosystems) using Boc chemistry to give Boc-Lys(Cl-Z)-Asp-
(OcHex)-Ala-Gln-Ala-Gly-Lys(Cl-Z)-Glu(OBzl)-Pro-Gly-SCH2CH2CO-
Leu-OCH2-Pam resin. This resin was treated with hydrogen fluoride
containing anisole (10%) on an ice bath for 1.5 h. After evaporation of the
hydrogen fluoride, the mixture was washed with ether and freeze-dried.
The peptide, 11, was purified by RP-HPLC [Cosmosil 5C18AR-II (10 ×
250 mm), 0.1% TFA in aqueous acetonitrile]: MS (MALDI-TOF) found
Peptide 10 was condensed with a peptide thioester, Lys-
Asp-Ala-Gln-Ala-Gly-Lys-Glu-Pro-Gly-SCH2CH2CO-Leu-
OH (11),18 in neutral phosphate buffer (pH 7.2) containing
6 M guanidine hydrochloride and 0.20 M thiophenol19
(14) Dixon, H. B. F. J. Protein Chem. 1984, 3, 99-108.
1160.0 (MH+), calcd 1159.5. Amino acid analysis: Asp0.99Glu2.0Pro0.78
Gly2.1Ala3Lys2.0
-
(15) Rose, K.; Chen, J.; Dragovic, M.; Zeng, W.; Jeannerat, D.;
Kamalaprija, P.; Burger, U. Bioconjugate Chem. 1999, 10, 1038-1043.
(16) Amine 8 was prepared by the reaction of 4,5-dimethoxy-2-
mercaptobenzylamine and triphenylmethanol in TFA: 55% yield; 1H NMR
(400 MHz, CDCl3) δ 3.36 (s, 3H), 3.62 (s, 2H), 3.85 (s, 3H), 6.70 (s, 1H),
6.91 (s, 1H), 7.19-7.31 (m, 15H); 13C NMR (100 MHz, CDCl3) δ 41.18,
55.58, 55.98, 71.37, 113.22, 118.77, 124.13, 127.33, 127.96, 130.03, 131.29,
143.66, 149.09, 150.71; MS (FAB) 442 (MH+), calcd 442.
.
(19) Dawson, P. E.; Churchill, M. J.; Ghadiri, M. R.; Kent, S. B. H. J.
Am. Chem. Soc. 1997, 119, 4325-4329.
(20) Peptides 10 (3.0 mg, 1.9 µmol) and 11 (4.2 mg, 2.8 µmol) were
dissolved in 50 mM sodium phosphate buffer (pH 7.2, 0.95 mL) containing
6 M guanidine hydrochloride in the presence of thiophenol (20 µL). After
stirring for 25 h, dithiothreitol (30 mg) was added, the mixture was stirred
for an additional 1 h, and product 12 was purified by RP-HPLC [Cosmosil
5C18AR-II (4.6 × 250 mm), 0.1% TFA in aqueous acetonitrile] (5.2 mg,
1.6 µmol, 85%): MS (MALDI-TOF) found 2243.7 (MH+), calcd 2243.5
(average). Amino acid analysis: Asp1.1Ser2.5Glu2.2Pro0.98Gly2.3Ala3.2Leu1-
(17) A solution of sodium cyanoborohydride (1.6 mg, 25 µmol) in DMF
(0.10 mL) was added to a solution of peptide 7 (7.2 mg, 5.0 µmol) and
amine 8 (22 mg, 50 µmol) in DMF (0.90 mL) containing acetic acid (8.0
µL). After stirring for 24 h, product 9 was purified by RP-HPLC [Cosmosil
5C18AR-II (4.6 × 250 mm), 0.1% TFA in aq acetonitrile] (3.7 mg, 1.9
µmol, 38%): MS (MALDI-TOF) found 1260.4 [(M - Trt + H)+], calcd
Lys3.3His1.8Arg0.94
.
(21) Peptide 12 (5.2 mg, 1.6 µmol) was treated with 1 M TFMSA and
1 M thioanisole in TFA (0.20 mL) on an ice bath for 1 h, and the mixture
was then washed with ether and freeze-dried. The product, 13, was purified
by RP-HPLC [Cosmosil 5C18AR-II (4.6 × 250 mm), 0.1% TFA in aqueous
acetonitrile] (1.6 mg, 0.73 µmol, 45%): MS (MALDI-TOF) found 2061.1
1260.6. Amino acid analysis: Ser2.5GlyndAla1.1Leu1Lys0.89His1.8Arg0.87
.
Peptide 9 was treated with TFA in the presence of triisopropylsilane (5%)
for 0.5 h and then washed with ether and dried in vacuo. The residue was
used for condensation with peptide 10: MS (MALDI-TOF) found 1260.9
(MH+), calcd 1260.6.
(MH+), calcd 2061.3 (average). Amino acid analysis: Asp0.99Ser2.7Glu2.1
-
Pro1.2Gly2.9Ala2.9Leu1Lys2.9His1.9Arg0.99
.
Org. Lett., Vol. 3, No. 9, 2001
1405